PRESTIGE® WNV

(West Nile virus, killed)

OVERVIEW

THE SCIENCE OF ADVANCED

An effective vaccine for West Nile virus in horses.

  • WNV is considered a core vaccination recommended by the AAEP vaccine guidelines and is indicated in the immunization program for all horses each year.
  • Advanced filtration process through the Antigen Purification System (APS™)
  • Exceptional safety profile with the exclusive Havlogen® Adjuvant

INDICATIONS

This product has been shown to be effective for the vaccination of healthy horses 6 months of age or older against West Nile Virus. Duration of immunity has not been established. For more information regarding safety and efficacy data, go to productdata.aphis.usda.gov. This product has been shown to be effective against encephalitis and viremia caused by West Nile Virus.

ADMINISTRATION

Dose
For primary vaccination aseptically administer 1 mL intramuscularly, repeat with a single dose in 3 – 4 weeks. Historically, annual revaccination with this product has been recommended. The need for this booster has not been established. The presence of maternal antibody is known to interfere with the development of active immunity in foals and additional boosters will be required in most young animals. For more information on revaccination frequency, consult your veterinarian.

RESOURCES

Learn more about the updated line of PRESTIGE vaccines.

Equine Product Reference Guide

A guide to the entire equine product line from Merck Animal Health.

Download

The Science of West Nile Protection

Customize your West Nile protection to the patient, with high degrees of safety for the horse and convenience for you.  

Download

No items to show.

Loading…